Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats.

Clatterbuck RE, Oshiro EM, Hoffman PA, Dietsch GN, Pardoll DM, Tamargo RJ.

J Neurosurg. 2002 Sep;97(3):676-82.

PMID:
12296653
2.

Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats.

Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ.

Stroke. 1997 Oct;28(10):2031-7; discussion 2037-8.

3.

Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates.

Clatterbuck RE, Gailloud P, Ogata L, Gebremariam A, Dietsch GN, Murphy KJ, Tamargo RJ.

J Neurosurg. 2003 Aug;99(2):376-82.

PMID:
12924713
4.

Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits.

Pradilla G, Wang PP, Legnani FG, Ogata L, Dietsch GN, Tamargo RJ.

J Neurosurg. 2004 Jul;101(1):88-92.

PMID:
15255256
6.
8.

Neutralizing antibody against interleukin-6 attenuates posthemorrhagic vasospasm in the rat femoral artery model.

Bowman G, Dixit S, Bonneau RH, Chinchilli VM, Cockroft KM.

Neurosurgery. 2004 Mar;54(3):719-25; discussion 725-6.

PMID:
15028149
9.

Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis.

Whitcup SM, DeBarge LR, Caspi RR, Harning R, Nussenblatt RB, Chan CC.

Clin Immunol Immunopathol. 1993 May;67(2):143-50.

PMID:
8100190
10.

Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury.

Ghielli M, Verstrepen WA, De Greef KE, Helbert MH, Ysebaert DK, Nouwen EJ, De Broe ME.

Kidney Int. 2000 Sep;58(3):1121-34. Erratum in: Kidney Int 2000 Nov;58(5):2257.

11.

Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm.

Sills AK Jr, Clatterbuck RE, Thompson RC, Cohen PL, Tamargo RJ.

Neurosurgery. 1997 Aug;41(2):453-60; discussion 460-1.

PMID:
9257314
12.

Role of anti-LFA-1 and anti-ICAM-1 combined MAb treatment in the rejection of tumors induced by Moloney murine sarcoma virus (M-MSV).

Rosato A, Mandruzzato S, Bronte V, Zambon A, Macino B, Calderazzo F, Zanovello P, Collavo D.

Int J Cancer. 1995 May 4;61(3):355-62.

PMID:
7729948
13.

Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection.

Miwa S, Isobe M, Suzuki J, Makuuchi M, Miyasaka M, Yamazaki S, Kawasaki S.

Surgery. 1997 Jun;121(6):681-9.

PMID:
9186469
14.

Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis.

Whitcup SM, Chan CC, Kozhich AT, Magone MT.

Clin Immunol. 1999 Nov;93(2):107-13.

PMID:
10527686
15.

Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection.

Ohta Y, Gotoh M, Ohzato H, Fukuzaki T, Nishihara M, Dono K, Umeshita K, Sakon M, Yagita H, Okumura K, Tanaka T, Kawashima H, Miyasaka M, Monden M.

Transplantation. 1998 Apr 27;65(8):1094-100.

PMID:
9583871
16.

Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.

Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS.

Stroke. 1998 Sep;29(9):1930-5; discussion 1935-6.

17.

Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis.

Whitcup SM, Hikita N, Shirao M, Miyasaka M, Tamatani T, Mochizuki M, Nussenblatt RB, Chan CC.

Exp Eye Res. 1995 Jun;60(6):597-601.

PMID:
7641842
18.
20.

Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.

Nishikawa K, Guo YJ, Miyasaka M, Tamatani T, Collins AB, Sy MS, McCluskey RT, Andres G.

J Exp Med. 1993 Mar 1;177(3):667-77.

Items per page

Supplemental Content

Write to the Help Desk